Hilltop National Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48.4K Sell
201
-68
-25% -$14.9K 0.01% 494
2026
Q1
$50.9K Buy
269
+59
+28% +$10.3K 0.01% 470
2025
Q4
$35.7K Buy
+210
New +$32.2K 0.01% 506

Other funds holding JAZZ

Hilltop National Bank's JAZZ Position: Q2 2026 in Review

Hilltop National Bank reduced its Jazz Pharmaceuticals (JAZZ) stake by 25% in Q2 2026, selling an estimated $14.9K and leaving 201 shares worth $48.4K. The position accounts for 0.01% of the portfolio, ranked #494.

Hilltop National Bank first reported a position in JAZZ in Q4 2025 and has held it in 3 quarters since. The position peaked at $50.9K in Q1 2026. 131 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Hilltop National Bank held 201 shares of Jazz Pharmaceuticals worth $48.4K as of Q2 2026.
  • Hilltop National Bank sold 68 Jazz Pharmaceuticals shares in Q2 2026, an estimated $14.9K.
  • Jazz Pharmaceuticals made up 0.01% of Hilltop National Bank's portfolio in Q2 2026, its #494 holding.
  • Hilltop National Bank first reported a position in Jazz Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Hilltop National Bank's Jazz Pharmaceuticals position peaked at $50.9K in Q1 2026.
  • 131 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Hilltop National Bank's 13F filing for Q2 2026, filed 2 Jul 2026.